Tomoki Sumida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tomoki Sumida has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Hamakawa
4 shared publicationsHiroaki Tanioka
Department of Oral Surgery
2 shared publications- Pierre-Yves Desprez
Buck Institute for Research on Aging, Novato, USA
2 shared publications Akiko Ishikawa
1 shared publication- Akiko Onishi-Ishikawa
Department of Oral and Maxillofacial Surgery, Ehime University School of Medicine, 454 Shitsukawa, Toon-City, Ehime, 791-0295, Japan
1 shared publication Ayumi Kobayashi
Department of Anesthesiology and Resuscitology, Ehime University Graduate School of Medicine, Ehime, Japan
1 shared publication
Latest Publications
- Open Access
- 22 March 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 141
Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells
Salivary gland cancer (SGC) is one of the common malignancies of the head and neck area. It develops in the minor and major salivary glands and sometimes metastasizes to other organs, particularly to the lungs. Inhibitors of differentiation (Id) proteins are negative regulators of basic helix-loop-helix transcription factors that control malignant cell behavior and tumor aggressiveness in many tissues. In this study, our goal was to determine the potential role of Id proteins, particularly Id1, during human SGC cell progression.
- 22 March 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 141
Open AccessTargeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells
Salivary gland cancer (SGC) is one of the common malignancies of the head and neck area. It develops in the minor and major salivary glands and sometimes metastasizes to other organs, particularly to the lungs. Inhibitors of differentiation (Id) proteins are negative regulators of basic helix-loop-helix transcription factors that control malignant cell behavior and tumor aggressiveness in many tissues. In this study, our goal was to determine the potential role of Id proteins, particularly Id1, during human SGC cell progression.
- 1 October 2012
- Vol. 5 (8) , 830-3
Epulis-like gingival angiosarcoma of the mandible: a case report.
A 55-year-old woman consulted our hospital for an epulis-like small mass in the anterior region of the mandible. A biopsy of the tumor was performed. Histological analysis showed that the tumor consisted of spindle-shaped and polygonal cells with hyperchromatic nuclei, and intracytoplasmic vacuoles and mitotic figures were scattered. Immunohistochemical staining revealed that the tumor cells were positive for factor VIII-related antigen, CD31, αSMA, and vimentin, but negative for pancytokeratins, S100 protein, neuron-specific enolase, and CD56. The Ki-67 labeling index was more than 50%. Based on these findings, a final pathological diagnosis of angiosarcoma was made. The tumor did not invade into the surrounding tissue. The operation was performed with about a 20-mm surgical margin that was negative for tumor invasion. After a 4-year follow-up, no metastatic lesions were found, and the primary site was covered with a partial denture.
- 1 October 2012
- Vol. 5 (8) , 830-3
Epulis-like gingival angiosarcoma of the mandible: a case report.
A 55-year-old woman consulted our hospital for an epulis-like small mass in the anterior region of the mandible. A biopsy of the tumor was performed. Histological analysis showed that the tumor consisted of spindle-shaped and polygonal cells with hyperchromatic nuclei, and intracytoplasmic vacuoles and mitotic figures were scattered. Immunohistochemical staining revealed that the tumor cells were positive for factor VIII-related antigen, CD31, αSMA, and vimentin, but negative for pancytokeratins, S100 protein, neuron-specific enolase, and CD56. The Ki-67 labeling index was more than 50%. Based on these findings, a final pathological diagnosis of angiosarcoma was made. The tumor did not invade into the surrounding tissue. The operation was performed with about a 20-mm surgical margin that was negative for tumor invasion. After a 4-year follow-up, no metastatic lesions were found, and the primary site was covered with a partial denture.
- 14 July 2010
- Published by Wiley in Dental Traumatology
- Vol. 26 (4) , 363-365
Massive subcutaneous emphysema developing before surgery for mandibular fracture: a case report
Abstract – Preoperative massive subcutaneous emphysema before intubation is extremely rare. However, this complication may be potentially lethal, depend on the condition of air spreading. Subcutaneous emphysema which occurs intra‐ or postoperative period is sometimes iatrogenic because the air is introduced into the tissue space through the hole injured by the operation. But the emphysema in this case occurred preoperatively by the pressure of the bag valve mask, because the patient had an intra‐oral wound, which reaches the submental space. In this report, we describe an extremely rare case of preoperative massive emphysema of the patient with the mandibular fracture.
- 14 July 2010
- Published by Wiley in Dental Traumatology
- Vol. 26 (4) , 363-365
Massive subcutaneous emphysema developing before surgery for mandibular fracture: a case report
Abstract – Preoperative massive subcutaneous emphysema before intubation is extremely rare. However, this complication may be potentially lethal, depend on the condition of air spreading. Subcutaneous emphysema which occurs intra‐ or postoperative period is sometimes iatrogenic because the air is introduced into the tissue space through the hole injured by the operation. But the emphysema in this case occurred preoperatively by the pressure of the bag valve mask, because the patient had an intra‐oral wound, which reaches the submental space. In this report, we describe an extremely rare case of preoperative massive emphysema of the patient with the mandibular fracture.
- 1 November 2003
- Vol. 63 (21) , 7098-105
Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
Id proteins are inhibitors of basic helix-loop-helix transcription factors and generally stimulate cell proliferation and inhibit differentiation. We have shown that ectopic expression of Id-1 in murine mammary epithelial cells resulted in loss of differentiation and gain of invasive and proliferative abilities. Moreover, Id-1 was highly expressed in aggressive breast cancer cells in culture and in biopsies from infiltrating carcinomas. In contrast to Id-1, we found that, in vitro and in vivo, Id-2 mRNA and protein were up-regulated as mammary epithelial cells lost proliferative capacity and initiated differentiation. We further determined that this up-regulation of Id-2 was a necessary step toward a fully differentiated phenotype in breast cells. Here we show that one of the components of the extracellular matrix network, laminin, is responsible for the increase in Id-2 expression during differentiation. We also show that Id-2 expression is inversely correlated with the rate of proliferation in murine mammary epithelial cells and that Id-2 is expressed at a higher level in differentiated human breast cancer cells in comparison with very aggressive and metastatic cells. When reintroduced in aggressive breast cancer cells, Id-2 is able to reduce their proliferative and invasive phenotypes and decrease their level of matrix metalloproteinase 9 secretion as well as increase syndecan-1 expression. Moreover, little Id-2 protein expression is detectable in human biopsies from aggressive and invasive carcinomas in comparison with in situ carcinomas. In conclusion, Id-2 expression not only follows a pattern opposite to that of Id-1 during mammary gland development and breast cancer progression but also appears to act as an important protein for the maintenance of a differentiated and noninvasive phenotype in normal and transformed breast cells.
- 1 November 2003
- Vol. 63 (21) , 7098-105
Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
Id proteins are inhibitors of basic helix-loop-helix transcription factors and generally stimulate cell proliferation and inhibit differentiation. We have shown that ectopic expression of Id-1 in murine mammary epithelial cells resulted in loss of differentiation and gain of invasive and proliferative abilities. Moreover, Id-1 was highly expressed in aggressive breast cancer cells in culture and in biopsies from infiltrating carcinomas. In contrast to Id-1, we found that, in vitro and in vivo, Id-2 mRNA and protein were up-regulated as mammary epithelial cells lost proliferative capacity and initiated differentiation. We further determined that this up-regulation of Id-2 was a necessary step toward a fully differentiated phenotype in breast cells. Here we show that one of the components of the extracellular matrix network, laminin, is responsible for the increase in Id-2 expression during differentiation. We also show that Id-2 expression is inversely correlated with the rate of proliferation in murine mammary epithelial cells and that Id-2 is expressed at a higher level in differentiated human breast cancer cells in comparison with very aggressive and metastatic cells. When reintroduced in aggressive breast cancer cells, Id-2 is able to reduce their proliferative and invasive phenotypes and decrease their level of matrix metalloproteinase 9 secretion as well as increase syndecan-1 expression. Moreover, little Id-2 protein expression is detectable in human biopsies from aggressive and invasive carcinomas in comparison with in situ carcinomas. In conclusion, Id-2 expression not only follows a pattern opposite to that of Id-1 during mammary gland development and breast cancer progression but also appears to act as an important protein for the maintenance of a differentiated and noninvasive phenotype in normal and transformed breast cells.
- 1 August 2001
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 30 (7) , 443-447
A case of submandibular malignant rhabdoid tumor transformed from papillary thyroid carcinoma
- 1 August 2001
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 30 (7) , 443-447
A case of submandibular malignant rhabdoid tumor transformed from papillary thyroid carcinoma
- 1 May 2001
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 59 (5) , 568-571
Leiomyosarcoma of the maxillary sinus with cervical lymph node metastasis
- 1 May 2001
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 59 (5) , 568-571
Leiomyosarcoma of the maxillary sinus with cervical lymph node metastasis